This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells 2 (Trem2), C-Fc
Product Overview
BioVenic's Recombinant Mouse Triggering Receptor Expressed on Myeloid Cells 2 (Trem2), C-Fc is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 24.5 kDa. The purity is>90%.
Specifications
Target Information
Mouse Triggering Receptor Expressed on Myeloid Cells 2 (Trem2) is involved in immune regulation and neurodegenerative diseases. It plays a role in microglial function, the immune cells of the central nervous system. Trem2 has been implicated in Alzheimer's disease, where it may influence disease progression and neuroinflammation. In other neurodegenerative conditions, Trem2 may modulate immune responses. This protein is a potential target for therapeutic intervention aiming to modify disease progression and manage neuroinflammation.
Trem2a; Trem2b; Trem2c
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.